← Open Payments lookup

DEBORAH GREENGRASS: Open Payments

NPI 1134288491 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$699 in 33 payments from 11 companies in 2025. Trend: 2023 $152 · 2024 $429 · 2025 $699

Food & beverage: $614Education: $85
CompanyPaymentsAmount
Astellas Pharma US Inc7$201
AstraZeneca Pharmaceuticals LP8$145
Merck Sharp & Dohme LLC4$81
Caris MPI, Inc.3$73
Tempus AI, Inc2$42
GlaxoSmithKline, LLC.2$38
ABBVIE INC.2$34
Sumitomo Pharma America, Inc.2$31
Verastem, Inc.1$20
VERTEX PHARMACEUTICALS INCORPORATED1$18

Products named: LYNPARZA, Veozah, MI CANCER SEEK, KEYTRUDA, XT CDX, JEMPERLI, ELAHERE, MYFEMBREE.

Industry payments across NJ — which companies pay providers there.